Medical Weight Loss for Elmhurst, Illinois Residents

Elmhurst, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Elmhurst through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Elmhurst: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Illinois. Results vary. Doctor review just $119 (medication separate).

Why Elmhurst Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Elmhurst is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across Illinois trust us to guide a serious decision about their health.

From our Costa Mesa, California practice, we provide Elmhurst with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

The care you would find at our Costa Mesa clinic follows you home to Elmhurst through telehealth, giving Illinois patients the same physician oversight without a single mile of travel. We care for patients throughout downtown Elmhurst and the western Chicago suburbs of DuPage County. Semaglutide starts from $166 a month, or $499 for the 90-day program, and tirzepatide from $233 a month, the same pricing for every Illinois patient.

Patients on the outskirts of Illinois get the same flat pricing, the same physician, and the same fast start as those near the center of Elmhurst. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. From the big cities to the small towns of Illinois, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for Elmhurst patients.

How Telehealth Works for Elmhurst

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Elmhurst address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Elmhurst

Does New Hope Weight Loss actually serve Elmhurst, or only Costa Mesa?

We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Elmhurst, Illinois through telehealth. Residents across neighborhoods like downtown Elmhurst and the western Chicago suburbs of DuPage County qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.

Can the whole process be done remotely from Elmhurst?

Yes, it is fully remote. There is no in-person requirement for Elmhurst patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.

How much will a Elmhurst patient pay?

Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Elmhurst residents pay no added distance fee.

What areas of Elmhurst do you serve?

We serve patients from across Elmhurst by telehealth, including downtown Elmhurst and the western Chicago suburbs of DuPage County.

What support is there for side effects for Elmhurst patients?

Dr. Sharma starts Elmhurst patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.

Elmhurst Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Elmhurst, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.